Tweets
A New ACR
Dr. Jack Cush highlights a few notable changes to the ACR meeting format this year, and offers pointers on the best way to stay informed and abreast of reporting from the #ACR24 Convergence meeting in Washington, DC.
https://t.co/YmI6s1TanV https://t.co/hsByGEBtnz
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 year 2 months ago
A#2648
PET for GCA
Delayed imaging at 180 min improve dx performance for pts on GCs
Optimal PET w/in 3 days of GC, most patients unable to do w/in that window
Delay has sensitivity 92% even on prednisone - may be good tool for pts unable to get early PET/CT
#ACR24 @RheumNow https://t.co/kxpNfRqkGN
Links:
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Study by Maria Dall'Era et al. compared voclosporin-based triple immunosuppressive therapy with high-dose GC in active lupus nephritis.
- Fewer adverse events in the voclosporin group, despite a higher incidence of specific issues like decreased GFR and hypertension.
- 25%… https://t.co/ToRu2rdErC https://t.co/uUXzNNuLDb
Links:
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
@YooJinKimYJK @andreafava et al: 20% of pts in their #lupus cohort had recurrent pericarditis.
Majority had 1 recurrence (51%)
Independent predictors of recurrence:
Younger age
Prednisone tx
Active dse
Time from initial episode
🔅regular ffup is 🔑
@RheumNow #ACR24 abs2372 https://t.co/UELwE31X0u
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
➡️More DMARD-exposed pts w late-onset RA reduce long-term GC use than DMARD-unexposed
➡️Persistent GC use is common
➡️In DMARD-exposed, GC use may be related to limited access to high-cost drugs
➡️In DMARD-unexposed, comorbidity burden may limit DMARD use
Ab2606 #ACR24 @RheumNow
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 2 months ago
How do you manage DMARDs when giving the recombinant #zoster #vaccine (#RZV)?
➡️75 pts with ARDs
💉2-week #MTX discontinuation after each dose of RZV
⏩Significant boost in immune response without difference in flare rates
Ab2612 #ACR24 @RheumNow https://t.co/o4iqj3e1Be
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 2 months ago
A#2649
Relapsing Polychondritis
Latent Class Analysis to define clinical phenotypes of heterogeneous dx
Type 1- ear, nose, subglottic stenosis
2- tracheo/bronchomalacia
3- absence tracheomalacia
Decision tree to classify pts in subgroups
#ACR24 @RheumNow https://t.co/xpZedPVl7f
Links:
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Loiseau et al. 4700 pSS, 47000 comparators. pSS associated with increased risk of every CV/VTE outcome. Did not have that in my priors! @RheumNow #ACR24 Abstr#2631 https://t.co/QKemUhbcG8 https://t.co/twpjdS2L63
Links:
Richard Conway @RichardPAConway ( View Tweet )
1 year 2 months ago
A#2650
MRI can show extent of vessel wall inflamm to guide severity of GCA
Brain & orbital MRI performed
Assessed 7 arteries bilaterally -> CAMRIS-GCA MRI score (0-10)
33 GCA (17 ocular), 41 not GCA
CAMRIS-GCA ass w/ ocular GCA, higher severity. Improved w Rx
@RheumNow #ACR24 https://t.co/19XCuZJXqF
Links:
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Among axSpA patients enrolled in the BE MOBILE 1&2, those who received Bimekizumab achieved ASAS40 response earlier vs PBO
Improvements in spinal pain and physical function were significantly reported as early as wk 1 in those who received BKZ vs PBO
@RheumNow #ACR24 abs2363 https://t.co/JmcQdURTY4
Links:
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
A re-evaluation of lupus arthritis. Old dogma is RA is erosive and SLE non-erosive. With better imaging, lupus arthritis can be erosive. Vivianne Malstrom. @RheumNow #ACR24 https://t.co/JEqVPLGNfu
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
Did you know?
#Lupus arthritis have clinical and US classifications.
On MRI, findings will show:
- periarticular hyperplastic tissue
- capsular swelling
- edematous tenosynovitis
@RheumNow #ACR24 @rheumarhyme @theactiverheum https://t.co/EoKh2Q3V9Z
Links:
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago


